Searchable abstracts of presentations at key conferences in endocrinology

ea0090oc6.6 | Oral Communications 6: Endocrine-related Cancer | ECE2023

Cellular landscape of adrenocortical carcinomas determined by molecular profiling of primary, recurrent and metastatic tumour samples at single-nuclei resolution.

Altieri Barbara , S. Tourigny David , Secener Ali Kerim , Sbiera Silviu , Arampatzi Panagiota , Sauer Sascha , Fassnacht Martin , Ronchi Cristina

Background: Molecular mechanisms of malignant adrenocortical tumorigenesis remain elusive despite previous comprehensive genomic studies. Nonetheless, cellular heterogeneity of primary, recurrent and metastatic adrenocortical carcinoma (ACC) haven’t been fully investigated.Aim: To characterize the molecular profile of different cell subtypes in primary, recurrent and metastatic ACC by single-nuclei RNA sequencing (snRNA-Seq), using adult human norma...

ea0094oc2.3 | Endocrine Cancer and Late Effects | SFEBES2023

Cellular landscape of adrenocortical carcinomas at single-nuclei resolution

Tourigny David , Altieri Barbara , Secener Kerim , Sbiera Silviu , Schauer Marc , Arampatzi Panagiota , Sauer Sascha , Fassnacht Martin , Ronchi Cristina

BackgroundAdrenocortical carcinoma (ACC) is a rare but devastating tumour of the adrenal gland and the molecular mechanisms of pathogenesis remain incompletely understood. To gain novel insights into the cellular landscape of ACC, we compared single nuclei RNA sequencing (snRNA-seq) datasets from ACC and normal adrenal glands (NAGs).Methods: We isolated single nuclei from 12 ACC snap-frozen samples, including 6 primary tumours, 3 local r...

ea0099p432 | Adrenal and Cardiovascular Endocrinology | ECE2024

Role of ccfDNA-based biomarkers in classification of adrenocortical adenomas

Xu Mengjie , Tourigny David S , Lippert Juliane , Crastin Ana , Appenzeller Silke , Asia Miriam Felicitas , Podstawka Oskar , Elhassan Yasir , Skordilis Kassiani , Prete Alessandro , Ronchi Cristina L

Background: Adrenocortical adenomas (ACA) can be associated with different degrees of cortisol excess. Genetic alterations in the cAMP/PKA pathway are observed in up to 60% of cases with overt Cushing syndrome (CS-ACA) and 15% of cases with mild autonomous cortisol secretion (MACS-ACA), while variants in the gene coding for β-catenin (CTNNB1) are more frequent in MACS-ACA and non-functioning adrenal tumours (NFAT). We aimed to test whether somatic variants could ...